Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Solid Tumor 13 Leukemia, Myeloid, Acute 10 Carcinoma, Non-Small-Cell Lung 7 Advanced Solid Tumors 7 Breast Neoplasms 6 Solid Tumor 5 Pancreatic Neoplasms 5 Melanoma 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Solid Tumors 3 Recurrence 3 Myelodysplastic Syndromes 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Advanced Malignant Solid Tumor 3 Advanced Lung Cancer 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Triptorelin Pamoate 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Helping Behavior × Injections × Clear all

NCT04616729 2023-05-18

Depo-Trigger

Universitair Ziekenhuis Brussel

Phase 1/2 Unknown

Helping Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡